Alexandra Woo, John Nusstein, Melissa Drum, Sara Fowler, Al Reader, Ai Ni
{"title":"1.8 mL和3.6 mL 4%阿替卡因和1:100000肾上腺素在上颌第一磨牙颊部浸润后的Pulpal麻醉成功:一项前瞻性随机交叉研究。","authors":"Alexandra Woo, John Nusstein, Melissa Drum, Sara Fowler, Al Reader, Ai Ni","doi":"10.2344/anpr-70-03-01","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this prospective, randomized crossover study was to compare the peak incidence of success, onset, and incidence over time of pulpal anesthesia in maxillary first molars following a buccal infiltration of 1.8 mL or 3.6 mL of 4% articaine with 1:100 000 epinephrine.</p><p><strong>Methods: </strong>A total of 118 adults received 1.8 mL or 3.6 mL of 4% articaine with 1:100 000 epinephrine via buccal infiltration of the maxillary first molar at 2 separate appointments. Electric pulp testing (EPT) of the maxillary first molar was performed over 68 minutes.</p><p><strong>Results: </strong>There was no significant difference in the peak incidence of anesthetic success (85% and 92%, respectively) in the maxillary first molar between 1.8 mL and 3.6 mL. The difference in onset times (4.5 min for 1.8 mL vs 4.4 min for 3.6 mL) was not statistically significant. However, the 3.6-mL volume did produce a significantly higher incidence of pulpal anesthesia from minutes 48 to 68 compared with the 1.8-mL volume.</p><p><strong>Conclusion: </strong>There was no significant difference in peak incidence or onset of pulpal anesthesia in the maxillary first molar between 1.8 mL and 3.6 mL of articaine with epinephrine. The incidence of pulpal anesthesia was significantly higher with 3.6 mL of articaine at 48 minutes and beyond, but neither volume provided complete pulpal anesthesia for all subjects that lasted at least 60 minutes.</p>","PeriodicalId":94296,"journal":{"name":"Anesthesia progress","volume":"70 3","pages":"110-115"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11080968/pdf/","citationCount":"0","resultStr":"{\"title\":\"Success of Pulpal Anesthesia Following Buccal Infiltration of the Maxillary First Molar With 1.8 mL and 3.6 mL of 4% Articaine With 1:100,000 Epinephrine: A Prospective, Randomized Crossover Study.\",\"authors\":\"Alexandra Woo, John Nusstein, Melissa Drum, Sara Fowler, Al Reader, Ai Ni\",\"doi\":\"10.2344/anpr-70-03-01\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>The purpose of this prospective, randomized crossover study was to compare the peak incidence of success, onset, and incidence over time of pulpal anesthesia in maxillary first molars following a buccal infiltration of 1.8 mL or 3.6 mL of 4% articaine with 1:100 000 epinephrine.</p><p><strong>Methods: </strong>A total of 118 adults received 1.8 mL or 3.6 mL of 4% articaine with 1:100 000 epinephrine via buccal infiltration of the maxillary first molar at 2 separate appointments. Electric pulp testing (EPT) of the maxillary first molar was performed over 68 minutes.</p><p><strong>Results: </strong>There was no significant difference in the peak incidence of anesthetic success (85% and 92%, respectively) in the maxillary first molar between 1.8 mL and 3.6 mL. The difference in onset times (4.5 min for 1.8 mL vs 4.4 min for 3.6 mL) was not statistically significant. However, the 3.6-mL volume did produce a significantly higher incidence of pulpal anesthesia from minutes 48 to 68 compared with the 1.8-mL volume.</p><p><strong>Conclusion: </strong>There was no significant difference in peak incidence or onset of pulpal anesthesia in the maxillary first molar between 1.8 mL and 3.6 mL of articaine with epinephrine. The incidence of pulpal anesthesia was significantly higher with 3.6 mL of articaine at 48 minutes and beyond, but neither volume provided complete pulpal anesthesia for all subjects that lasted at least 60 minutes.</p>\",\"PeriodicalId\":94296,\"journal\":{\"name\":\"Anesthesia progress\",\"volume\":\"70 3\",\"pages\":\"110-115\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11080968/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anesthesia progress\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2344/anpr-70-03-01\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anesthesia progress","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2344/anpr-70-03-01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:本前瞻性随机交叉研究的目的是比较1.8 mL或3.6 mL 4%阿替卡因与1:100口腔浸润后上颌第一磨牙牙髓麻醉的成功率、发病率和随时间变化的发生率峰值 000肾上腺素。方法:共有118名成年人接受1.8 mL或3.6 mL 4%阿替卡因1:100 000肾上腺素通过上颌第一磨牙的颊侧浸润。上颌第一磨牙的电牙髓测试(EPT)在68分钟内进行。结果:在1.8 mL和3.6 mL之间,上颌第一磨牙麻醉成功的峰值发生率(分别为85%和92%)没有显著差异。发作时间(1.8 mL 4.5分钟和3.6 mL 4.4分钟)的差异没有统计学意义。然而,与1.8-mL容量相比,3.6-mL容量在48至68分钟内确实产生了显著更高的牙髓麻醉发生率。结论:1.8 mL阿替卡因和3.6 mL肾上腺素在上颌第一磨牙牙髓麻醉的峰值发生率或开始时间方面没有显著差异。在48分钟及以后使用3.6 mL阿替卡因时,牙髓麻醉的发生率明显更高,但这两种体积都不能为所有受试者提供持续至少60分钟的完全牙髓麻醉。
Success of Pulpal Anesthesia Following Buccal Infiltration of the Maxillary First Molar With 1.8 mL and 3.6 mL of 4% Articaine With 1:100,000 Epinephrine: A Prospective, Randomized Crossover Study.
Objective: The purpose of this prospective, randomized crossover study was to compare the peak incidence of success, onset, and incidence over time of pulpal anesthesia in maxillary first molars following a buccal infiltration of 1.8 mL or 3.6 mL of 4% articaine with 1:100 000 epinephrine.
Methods: A total of 118 adults received 1.8 mL or 3.6 mL of 4% articaine with 1:100 000 epinephrine via buccal infiltration of the maxillary first molar at 2 separate appointments. Electric pulp testing (EPT) of the maxillary first molar was performed over 68 minutes.
Results: There was no significant difference in the peak incidence of anesthetic success (85% and 92%, respectively) in the maxillary first molar between 1.8 mL and 3.6 mL. The difference in onset times (4.5 min for 1.8 mL vs 4.4 min for 3.6 mL) was not statistically significant. However, the 3.6-mL volume did produce a significantly higher incidence of pulpal anesthesia from minutes 48 to 68 compared with the 1.8-mL volume.
Conclusion: There was no significant difference in peak incidence or onset of pulpal anesthesia in the maxillary first molar between 1.8 mL and 3.6 mL of articaine with epinephrine. The incidence of pulpal anesthesia was significantly higher with 3.6 mL of articaine at 48 minutes and beyond, but neither volume provided complete pulpal anesthesia for all subjects that lasted at least 60 minutes.